Results 11 to 20 of about 171,917 (190)

Clinical and immunohistochemical findings of splenic mast cell tumour in a cat: A case report

open access: yesVeterinární Medicína, 2021
A 6-year-old, spayed, female, domestic shorthair cat presented with a 4-month history of chronic intermittent vomiting and anorexia. The haematologic results indicated moderate anaemia and a circulating mast cell population.
S Lee   +10 more
doaj   +1 more source

Pemphigus Herpetiformis in Childhood: Clinical Case

open access: yesВопросы современной педиатрии, 2023
Background. Pemphigus herpetiformis is a rare atypical bullous dermatosis of autoimmune nature. It is characterized by rashes in the form of plaques with papules and vesicles at peripheral areas, or in the form of grouped papules, vesicles or tense ...
Nikolay N. Murashkin   +10 more
doaj   +1 more source

Development of a gum recession model in an experiment

open access: yesЭндодонтия Today, 2023
Background: The article presents experimental studies conducted on Wistar rats in the amount of 50 individuals. An artificial gum recession defect was created.Aim: to evaluate the effectiveness of creating a gum recession model in the proposed way ...
N. V. Lopatina   +5 more
doaj   +1 more source

Immune-mediated polyarthritis in dogs: Are corticosteroids the best bet?

open access: yesVeterinary Evidence, 2023
PICO question In dogs with type I immune-mediated polyarthritis (IMPA), is sole treatment with other immunosuppressive agents as effective as treatment with corticosteroids at reducing clinical signs?
Hannah Walker
doaj   +1 more source

Post-Transplant Diabetes Mellitus in Renal Transplant Recipients, Single-Centre Data: Incidence, Risk Factors, and Effect on Graft Function and Mortality

open access: yesDubai Diabetes and Endocrinology Journal, 2023
Background: De novo post-transplant diabetes mellitus (PTDM) is a frequent complication among renal transplant recipients; it confers a high risk for graft failure and patient mortality.
Dileep Kumar   +9 more
doaj   +1 more source

In cats which treatment, meloxicam or prednisolone, most quickly reduces clinical signs of feline interstitial cystitis?

open access: yesVeterinary Evidence, 2022
PICO question In cats with feline interstitial cystitis, which therapy brings a faster resolution of clinical signs: meloxicam or prednisolone?   Clinical bottom line Category of research question Treatment The number and type of study ...
Thomas Smith-Uchotski
doaj   +1 more source

Prednisolone and prednisone pharmacokinetics in renal transplant recipients

open access: yes, 2022
The main findings of this study was the large variability in prednisolone and prednisone plasma concentrations between patients, even after adjusting for dose and bodyweight.
Skauby, Ragnhild Kristine Heier
core   +1 more source

Differential Behavior of Non-albicans Candida Species in the Central Nervous System of Immunocompetent and Immunosuppressed Mice

open access: yesFrontiers in Microbiology, 2019
The genus Candida includes commensal fungi that can cause local and systemic infections, frequently involving vital organs as the central nervous system (CNS). Candida spp. occupy the fourth place among infections that affect the CNS.
Marcelo D’Alessandre Sanches   +8 more
doaj   +1 more source

A phase two randomised controlled double blind trial of high dose intravenous methylprednisolone and oral prednisolone versus intravenous normal saline and oral prednisolone in individuals with leprosy type 1 reactions and/or nerve function impairment. [PDF]

open access: yes, 2011
BACKGROUND: Leprosy Type 1 reactions are a major cause of nerve damage and the preventable disability that results. Type 1 reactions are treated with oral corticosteroids and there are few data to support the optimal dose and duration of treatment.
Dhakal, Sushmita   +38 more
core   +1 more source

HIV Patients Treated with Low-dose Prednisolone Exhibit Lower Immune Activation than Untreated Patients. [PDF]

open access: yes, 2012
HIV-associated general immune activation is a strong predictor for HIV disease progression, suggesting that chronic immune activation may drive HIV pathogenesis. Consequently, immunomodulating agents may decelerate HIV disease progression.
Schmidt, Barabara   +30 more
core   +2 more sources

Home - About - Disclaimer - Privacy